These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7129522)

  • 21. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
    Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
    J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Deficiency of leukocyte glutathione reductase, deficiency of leukocyte glutathione peroxidase].
    Matsuzaki S; Komiyama A
    Ryoikibetsu Shokogun Shirizu; 2000; (32):144-5. PubMed ID: 11212669
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Tsai SM; Lin SK; Lee KT; Hsiao JK; Huang JC; Wu SH; Ma H; Wu SH; Tsai LY
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):394-400. PubMed ID: 19641006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of enzyme transducing extracellular signals--gamma glutamyltransferase and enzymes metabolizing glutathione in acute lymphoblastic and myeloid human leukemias.
    Rzymowska J
    Neoplasma; 1995; 42(2):53-6. PubMed ID: 7617077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An automated technique for the measurement of the plasma glutathione reductase activity and determination of reference limits for a healthy population.
    Hermes CL; Hausen BS; Sangoi MB; Almeida TC; De Carvalho JA; Gomes P; Moresco RN
    Clin Chem Lab Med; 2013 Feb; 51(2):e31-3. PubMed ID: 23641501
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum glutathione-S-transferase and glutathione reductase activity in head and neck cancer patients.
    Patel BP; Raval GN; Rawal RM; Patel JB; Sainger RN; Patel MM; Shah MH; Patel DD; Patel PS
    Neoplasma; 2002; 49(4):260-6. PubMed ID: 12382026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of two-stage weaning with subsequent transport on body weight, plasma lipid peroxidation, plasma selenium, and on leukocyte glutathione peroxidase and glutathione reductase activity in beef calves.
    Burke NC; Scaglia G; Boland HT; Swecker WS
    Vet Immunol Immunopathol; 2009 Feb; 127(3-4):365-70. PubMed ID: 19110316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vanadium (IV) formation in the reduction of vanadate by glutathione reductase/NADPH and the role of molecular oxygen.
    Shi X; Flynn DC; Liu K; Dalal N
    Ann Clin Lab Sci; 1997; 27(6):422-7. PubMed ID: 9433540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavins and flavoenzymes in diagnosis and therapy.
    Becker K; Schirmer M; Kanzok S; Schirmer RH
    Methods Mol Biol; 1999; 131():229-45. PubMed ID: 10494553
    [No Abstract]   [Full Text] [Related]  

  • 30. Pro-, antioxidant and rheologic studies in the blood of type 2 diabetic patients.
    Matkovics B; Kotormán M; Varga IS; Hai DQ; Salgó L; Novák Z
    Acta Physiol Hung; 1997-1998; 85(2):107-12. PubMed ID: 9706304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients.
    Mydlík M; Derzsiová K; Rácz O; Sipulová A; Lovásová E
    Prague Med Rep; 2006; 107(3):354-64. PubMed ID: 17385408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal and stable conditions for the determination of erythrocyte glutathione reductase activation coefficient to evaluate riboflavin status.
    Dror Y; Stern F; Komarnitsky M
    Int J Vitam Nutr Res; 1994; 64(4):257-62. PubMed ID: 7883462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic myeloid leukemia. Current strategies in diagnosis, therapy and follow-up].
    Hochhaus A; Hehlmann R
    Internist (Berl); 1996 Oct; 37(10):1013-21. PubMed ID: 9019445
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people.
    Solak ZA; Kabaroğlu C; Cok G; Parildar Z; Bayindir U; Ozmen D; Bayindir O
    Clin Exp Med; 2005 Oct; 5(3):99-105. PubMed ID: 16284731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Position paper of the Society of Pediatric Oncology and Hematology (GPOH) on (long-term) surveillance, (long-term) follow-up and late effect evaluation in pediatric oncology patients].
    Calaminus G; Kaatsch P
    Klin Padiatr; 2007; 219(3):173-8. PubMed ID: 17525912
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current leukemia therapy and its trends].
    Yamaguchi H
    Kango Gijutsu; 1980 Sep; 26(12):1555-60. PubMed ID: 6903602
    [No Abstract]   [Full Text] [Related]  

  • 37. [Enzymatic changes in the blood of patients with leukemia].
    Ledvina M
    Lek Veda Zahr; 1967 Sep; 1(9):Suppl:161-71. PubMed ID: 4864965
    [No Abstract]   [Full Text] [Related]  

  • 38. Leukemia. IV.
    Semin Hematol; 1987 Jul; 24(3):202-8. PubMed ID: 3659949
    [No Abstract]   [Full Text] [Related]  

  • 39. IV-evaluation of plasma glutathione reductase as a marker during therapy in leukemia patients.
    Talageri VR; Seshadri KN; Advani SH
    Indian J Cancer; 1982; 19(2):93-8. PubMed ID: 7129522
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of prognostic value of plasma phosphohexose isomerase levels in leukaemia patients during therapy.
    Seshadri KN; Talageri VR; Advani SH
    Indian J Cancer; 1982 Mar; 19(1):28-34. PubMed ID: 7106829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.